| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 4.34e-10 | 43 | 82 | 7 | GO:0030280 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.98e-04 | 130 | 82 | 5 | GO:0005200 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.61e-04 | 229 | 82 | 6 | GO:0140993 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 2.29e-08 | 75 | 84 | 7 | GO:0045109 | |
| GeneOntologyBiologicalProcess | keratinization | 6.47e-08 | 87 | 84 | 7 | GO:0031424 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.59e-07 | 99 | 84 | 7 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.70e-07 | 100 | 84 | 7 | GO:0045103 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 1.21e-05 | 189 | 84 | 7 | GO:0030216 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT2 KRT3 KRT5 KRT6A KRT6B KRT8 KRT76 KRT6C COL28A1 SPTAN1 DDR2 RICTOR PRKCQ NEB | 2.98e-05 | 957 | 84 | 14 | GO:0097435 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 1.60e-04 | 284 | 84 | 7 | GO:0009913 | |
| GeneOntologyCellularComponent | keratin filament | 4.75e-09 | 97 | 83 | 8 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.01e-06 | 263 | 83 | 9 | GO:0045111 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT2 KRT3 KRT5 KRT6A KRT6B DNAH3 KRT8 KRT76 KRT6C KIF26B COL28A1 PPP1R12B SPTAN1 SYNE2 NEB ZNF804A DUSP22 | 3.12e-06 | 1179 | 83 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | intermediate filament | 3.35e-06 | 227 | 83 | 8 | GO:0005882 | |
| GeneOntologyCellularComponent | supramolecular polymer | KRT2 KRT3 KRT5 KRT6A KRT6B DNAH3 KRT8 KRT76 KRT6C KIF26B COL28A1 PPP1R12B SPTAN1 SYNE2 NEB ZNF804A DUSP22 | 3.42e-06 | 1187 | 83 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT2 KRT3 KRT5 KRT6A KRT6B DNAH3 KRT8 KRT76 KRT6C KIF26B ZNF804A DUSP22 | 2.16e-04 | 899 | 83 | 12 | GO:0099513 |
| GeneOntologyCellularComponent | Z disc | 3.40e-04 | 151 | 83 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 5.24e-04 | 166 | 83 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 8.37e-04 | 11 | 83 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 8.37e-04 | 11 | 83 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | paranodal junction | 8.37e-04 | 11 | 83 | 2 | GO:0033010 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 8.37e-04 | 11 | 83 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 8.37e-04 | 11 | 83 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | paranode region of axon | 2.04e-03 | 17 | 83 | 2 | GO:0033270 | |
| HumanPheno | Follicular hyperkeratosis | 2.10e-05 | 30 | 29 | 4 | HP:0007502 | |
| HumanPheno | Epidermal thickening | KRT2 TRAPPC11 KRT5 KRT6A KRT6B KRT6C SYNE2 DDR2 NSMCE2 TRIP4 | 2.56e-05 | 379 | 29 | 10 | HP:0011368 |
| HumanPheno | Palmoplantar blistering | 2.66e-05 | 11 | 29 | 3 | HP:0007446 | |
| HumanPheno | Hyperkeratosis | 3.16e-05 | 233 | 29 | 8 | HP:0000962 | |
| HumanPheno | Palmoplantar keratoderma | 3.44e-05 | 114 | 29 | 6 | HP:0000982 | |
| HumanPheno | Abnormality of keratinization | 4.41e-05 | 244 | 29 | 8 | HP:0001035 | |
| HumanPheno | Palmoplantar hyperkeratosis | 6.91e-05 | 129 | 29 | 6 | HP:0000972 | |
| HumanPheno | Lower limb pain | 7.42e-05 | 41 | 29 | 4 | HP:0012514 | |
| HumanPheno | Palmar hyperkeratosis | 7.53e-05 | 131 | 29 | 6 | HP:0010765 | |
| HumanPheno | Thickened skin | KRT2 TRAPPC11 KRT5 KRT6A KRT6B KRT6C SYNE2 DDR2 NSMCE2 TRIP4 | 7.79e-05 | 431 | 29 | 10 | HP:0001072 |
| HumanPheno | Plantar hyperkeratosis | 7.86e-05 | 132 | 29 | 6 | HP:0007556 | |
| HumanPheno | Epidermoid cyst | 1.07e-04 | 45 | 29 | 4 | HP:0200040 | |
| HumanPheno | Cutaneous cyst | 1.76e-04 | 51 | 29 | 4 | HP:0025245 | |
| HumanPheno | Eruptive vellus hair cyst | 1.86e-04 | 4 | 29 | 2 | HP:0025248 | |
| HumanPheno | Steatocystoma multiplex | 1.86e-04 | 4 | 29 | 2 | HP:0012035 | |
| HumanPheno | Abnormality of the periungual region | 2.38e-04 | 22 | 29 | 3 | HP:0100803 | |
| HumanPheno | Limb pain | 2.72e-04 | 57 | 29 | 4 | HP:0009763 | |
| HumanPheno | Linear arrays of macular hyperkeratoses in flexural areas | 3.10e-04 | 5 | 29 | 2 | HP:0007490 | |
| HumanPheno | Hyperplastic callus formation | 3.10e-04 | 5 | 29 | 2 | HP:0030268 | |
| HumanPheno | Abnormality of the plantar skin of foot | 3.27e-04 | 171 | 29 | 6 | HP:0100872 | |
| HumanPheno | Blistering by anatomical location | 3.95e-04 | 26 | 29 | 3 | HP:0033800 | |
| HumanPheno | Prominent antitragus | 4.63e-04 | 6 | 29 | 2 | HP:0008593 | |
| HumanPheno | White lesion of the oral mucosa | 4.94e-04 | 28 | 29 | 3 | HP:0025125 | |
| HumanPheno | Oral leukoplakia | 4.94e-04 | 28 | 29 | 3 | HP:0002745 | |
| HumanPheno | Onychogryposis | 5.49e-04 | 29 | 29 | 3 | HP:0001805 | |
| HumanPheno | Onychogryposis of toenails | 6.46e-04 | 7 | 29 | 2 | HP:0008401 | |
| HumanPheno | Onychogryposis | 6.46e-04 | 7 | 29 | 2 | HP:0001819 | |
| Domain | Keratin_2_head | 8.25e-14 | 24 | 84 | 8 | IPR032444 | |
| Domain | Keratin_2_head | 8.25e-14 | 24 | 84 | 8 | PF16208 | |
| Domain | Keratin_II | 1.74e-13 | 26 | 84 | 8 | IPR003054 | |
| Domain | Intermediate_filament_CS | 3.77e-10 | 63 | 84 | 8 | IPR018039 | |
| Domain | Filament | 1.01e-09 | 71 | 84 | 8 | SM01391 | |
| Domain | IF | 1.13e-09 | 72 | 84 | 8 | PS00226 | |
| Domain | Filament | 1.26e-09 | 73 | 84 | 8 | PF00038 | |
| Domain | IF | 1.75e-09 | 76 | 84 | 8 | IPR001664 | |
| Domain | Keratin_I | 1.02e-03 | 44 | 84 | 3 | IPR002957 | |
| Domain | Ran_BP1 | 1.28e-03 | 12 | 84 | 2 | PF00638 | |
| Domain | GrpE_coiled_coil | 1.28e-03 | 12 | 84 | 2 | IPR013805 | |
| Domain | RANBD1 | 1.28e-03 | 12 | 84 | 2 | PS50196 | |
| Domain | His_Phos_1 | 1.28e-03 | 12 | 84 | 2 | PF00300 | |
| Domain | His_Pase_superF_clade-1 | 1.28e-03 | 12 | 84 | 2 | IPR013078 | |
| Domain | RanBD | 1.51e-03 | 13 | 84 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 1.51e-03 | 13 | 84 | 2 | IPR000156 | |
| Domain | His_PPase_superfam | 3.60e-03 | 20 | 84 | 2 | IPR029033 | |
| Domain | - | 3.60e-03 | 20 | 84 | 2 | 3.40.50.1240 | |
| Domain | - | 4.52e-03 | 74 | 84 | 3 | 3.40.50.410 | |
| Domain | Actinin_actin-bd_CS | 4.76e-03 | 23 | 84 | 2 | IPR001589 | |
| Domain | Spectrin | 4.76e-03 | 23 | 84 | 2 | PF00435 | |
| Domain | ACTININ_2 | 4.76e-03 | 23 | 84 | 2 | PS00020 | |
| Domain | ACTININ_1 | 4.76e-03 | 23 | 84 | 2 | PS00019 | |
| Domain | tRNA-bd_arm | 5.17e-03 | 24 | 84 | 2 | IPR010978 | |
| Domain | SH3_9 | 5.24e-03 | 78 | 84 | 3 | PF14604 | |
| Domain | VWFA | 6.02e-03 | 82 | 84 | 3 | PS50234 | |
| Domain | SH3_1 | 6.41e-03 | 164 | 84 | 4 | PF00018 | |
| Domain | VWA | 6.43e-03 | 84 | 84 | 3 | SM00327 | |
| Domain | Spectrin_repeat | 7.50e-03 | 29 | 84 | 2 | IPR002017 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.45e-07 | 129 | 66 | 8 | M27649 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 3.13e-06 | 87 | 66 | 6 | MM15351 | |
| Pathway | REACTOME_KERATINIZATION | 7.39e-06 | 217 | 66 | 8 | M27640 | |
| Pathway | REACTOME_KERATINIZATION | 7.87e-05 | 153 | 66 | 6 | MM15343 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.05e-04 | 502 | 66 | 10 | MM14537 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.01e-04 | 31 | 66 | 3 | M877 | |
| Pubmed | 1.23e-12 | 57 | 84 | 8 | 31862882 | ||
| Pubmed | DCAF1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT8 KRT76 KRT6C SPTAN1 RAB3GAP2 UBASH3B | 2.17e-12 | 266 | 84 | 12 | 19380743 | |
| Pubmed | 2.86e-12 | 63 | 84 | 8 | 16831889 | ||
| Pubmed | KRT2 KRT3 RGPD2 KRT5 KRT6A RANBP1 KRT6B KRT8 KRT76 KRT6C PPP1R12B SPTAN1 SYNE2 OGDHL PIP4K2B MPHOSPH10 NEB CADPS2 DNAJC3 TOP2B | 1.69e-10 | 1442 | 84 | 20 | 35575683 | |
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 3.12e-10 | 16 | 84 | 5 | 12399393 | |
| Pubmed | 4.73e-10 | 6 | 84 | 4 | 16790075 | ||
| Pubmed | Type II keratins precede type I keratins during early embryonic development. | 3.95e-09 | 9 | 84 | 4 | 16180309 | |
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 29357356 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 29587848 | ||
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 7543104 | ||
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 9054461 | ||
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 29884220 | ||
| Pubmed | Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. | 1.19e-07 | 19 | 84 | 4 | 17002498 | |
| Pubmed | Airway hillocks are injury-resistant reservoirs of unique plastic stem cells. | 1.35e-07 | 5 | 84 | 3 | 38693267 | |
| Pubmed | Role for keratins 6 and 17 during wound closure in embryonic mouse skin. | 1.35e-07 | 5 | 84 | 3 | 12557214 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 20301457 | ||
| Pubmed | Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12. | 1.35e-07 | 5 | 84 | 3 | 1713141 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 23075894 | ||
| Pubmed | AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. | 1.84e-07 | 21 | 84 | 4 | 18824566 | |
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 16239341 | ||
| Pubmed | p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration. | 2.70e-07 | 6 | 84 | 3 | 25383540 | |
| Pubmed | Transcriptomic analysis of the upper lip and primary palate development in mice. | 3.24e-07 | 24 | 84 | 4 | 36685938 | |
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 3.40e-07 | 113 | 84 | 6 | 34474245 | |
| Pubmed | 4.72e-07 | 7 | 84 | 3 | 19720911 | ||
| Pubmed | Identification of trichoplein, a novel keratin filament-binding protein. | 7.54e-07 | 8 | 84 | 3 | 15731013 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KRT8 STOX2 PDE3B KIF26B CLMN PPFIBP1 SPTAN1 RAB3GAP2 SYNE2 RICTOR NSMCE2 TSSK1B | 1.08e-06 | 861 | 84 | 12 | 36931259 |
| Pubmed | 1.10e-06 | 75 | 84 | 5 | 31527668 | ||
| Pubmed | 1.13e-06 | 9 | 84 | 3 | 15737194 | ||
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 1.25e-06 | 141 | 84 | 6 | 32322062 | |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 1.94e-06 | 84 | 84 | 5 | 29563501 | |
| Pubmed | Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA. | 2.94e-06 | 12 | 84 | 3 | 14610062 | |
| Pubmed | 3.24e-06 | 496 | 84 | 9 | 31343991 | ||
| Pubmed | 4.78e-06 | 46 | 84 | 4 | 36147463 | ||
| Pubmed | Two novel pleiotropic loci associated with osteoporosis and abdominal obesity. | 5.76e-06 | 2 | 84 | 2 | 32239398 | |
| Pubmed | Directed expression of a chimeric type II keratin partially rescues keratin 5-null mice. | 5.76e-06 | 2 | 84 | 2 | 24867950 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 11118885 | ||
| Pubmed | PDE3B regulates KRT6B and increases the sensitivity of bladder cancer cells to copper ionophores. | 5.76e-06 | 2 | 84 | 2 | 38165426 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 27732084 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 35527047 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 10550543 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 10550545 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 9790766 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 23662636 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 20138207 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 18784374 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 10444334 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 33075816 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 11489919 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 10866680 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 10953016 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6207530 | ||
| Pubmed | Cytokeratins mediate epithelial innate defense through their antimicrobial properties. | 5.76e-06 | 2 | 84 | 2 | 23006328 | |
| Pubmed | RABL2 positively controls localization of GPCRs in mammalian primary cilia. | 5.76e-06 | 2 | 84 | 2 | 30578315 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 33435173 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 6186379 | ||
| Pubmed | 7.22e-06 | 191 | 84 | 6 | 33762435 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 9.10e-06 | 564 | 84 | 9 | 21565611 | |
| Pubmed | 9.13e-06 | 54 | 84 | 4 | 35474131 | ||
| Pubmed | 1.39e-05 | 60 | 84 | 4 | 31220272 | ||
| Pubmed | 1.50e-05 | 20 | 84 | 3 | 38113115 | ||
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 1.53e-05 | 218 | 84 | 6 | 35831895 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.59e-05 | 605 | 84 | 9 | 28977666 | |
| Pubmed | 1.70e-05 | 222 | 84 | 6 | 35941108 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 17170733 | ||
| Pubmed | Making a connection: direct binding between keratin intermediate filaments and desmosomal proteins. | 1.73e-05 | 3 | 84 | 2 | 7525601 | |
| Pubmed | Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. | 1.73e-05 | 3 | 84 | 2 | 17650314 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 15601842 | ||
| Pubmed | A role for keratins in supporting mitochondrial organization and function in skin keratinocytes. | 1.73e-05 | 3 | 84 | 2 | 32213122 | |
| Pubmed | A deregulated integrated stress response promotes interferon-γ-induced medulloblastoma. | 1.73e-05 | 3 | 84 | 2 | 21688289 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 36888721 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 26522727 | ||
| Pubmed | Non-Muscle-Invasive Bladder Carcinoma with Respect to Basal Versus Luminal Keratin Expression. | 1.73e-05 | 3 | 84 | 2 | 33086575 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 21754978 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 17851587 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 14573483 | ||
| Pubmed | Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. | 1.73e-05 | 3 | 84 | 2 | 14568992 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 29425506 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 15247274 | ||
| Pubmed | Identification of a cloned sequence activated during multi-stage carcinogenesis in mouse skin. | 1.73e-05 | 3 | 84 | 2 | 1713533 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 24326984 | ||
| Pubmed | Homologs of Drosophila Fushi-Tarazu factor 1 map to mouse chromosome 2 and human chromosome 9q33. | 1.73e-05 | 3 | 84 | 2 | 7789992 | |
| Pubmed | Bcl11b/Ctip2 is required for development of lingual papillae in mice. | 1.75e-05 | 21 | 84 | 3 | 27287879 | |
| Pubmed | 2.32e-05 | 23 | 84 | 3 | 16459298 | ||
| Pubmed | 2.32e-05 | 23 | 84 | 3 | 19494835 | ||
| Pubmed | 2.65e-05 | 24 | 84 | 3 | 30719818 | ||
| Pubmed | 2.65e-05 | 24 | 84 | 3 | 27507811 | ||
| Pubmed | 2.75e-05 | 360 | 84 | 7 | 33111431 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 27693698 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 30389720 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 22264670 | ||
| Pubmed | Mouse models in preclinical studies for pachyonychia congenita. | 3.45e-05 | 4 | 84 | 2 | 16250208 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 26645692 | ||
| Pubmed | Cytokeratin expression during mouse embryonic and early postnatal mammary gland development. | 3.45e-05 | 4 | 84 | 2 | 19937336 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 23327593 | ||
| Pubmed | Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. | 3.45e-05 | 4 | 84 | 2 | 25559258 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 19598115 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 17577402 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 11567631 | ||
| Pubmed | KRT2 KRT5 KRT6A KRT6B KRT76 CLMN PPP1R12B ARHGAP26 SPTAN1 OGDHL NFASC CPNE4 PRKRA | 3.78e-05 | 1431 | 84 | 13 | 37142655 | |
| Pubmed | mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation. | 3.81e-05 | 27 | 84 | 3 | 27807348 | |
| Interaction | KRT28 interactions | 3.25e-15 | 30 | 84 | 9 | int:KRT28 | |
| Interaction | PHTF1 interactions | 7.83e-15 | 20 | 84 | 8 | int:PHTF1 | |
| Interaction | KRT25 interactions | 1.39e-12 | 35 | 84 | 8 | int:KRT25 | |
| Interaction | KRT12 interactions | 5.53e-12 | 24 | 84 | 7 | int:KRT12 | |
| Interaction | KRT84 interactions | 2.54e-11 | 49 | 84 | 8 | int:KRT84 | |
| Interaction | KRT20 interactions | 2.08e-10 | 63 | 84 | 8 | int:KRT20 | |
| Interaction | KRT14 interactions | KRT2 KRT3 KRT5 KRT6A KRT6B KRT8 KRT76 KRT6C CCNB3 RICTOR UBASH3B | 4.47e-10 | 192 | 84 | 11 | int:KRT14 |
| Interaction | KRT36 interactions | 7.81e-10 | 74 | 84 | 8 | int:KRT36 | |
| Interaction | RNF208 interactions | 8.71e-10 | 75 | 84 | 8 | int:RNF208 | |
| Interaction | DES interactions | 1.11e-09 | 158 | 84 | 10 | int:DES | |
| Interaction | KRT6A interactions | 1.25e-09 | 160 | 84 | 10 | int:KRT6A | |
| Interaction | KRT8 interactions | KRT2 KRT3 TRAPPC11 KRT5 KRT6A KRT6B KRT8 GRIPAP1 KRT76 KRT6C NDC80 RICTOR UBASH3B GFRA1 | 3.70e-09 | 441 | 84 | 14 | int:KRT8 |
| Interaction | CRK interactions | KRT2 KRT3 KRT5 KRT6A KRT6B KRT8 KRT76 GABPB2 EPYC KAT6A RICTOR UBASH3B ZNF804A | 4.21e-09 | 370 | 84 | 13 | int:CRK |
| Interaction | KRT26 interactions | 6.44e-09 | 35 | 84 | 6 | int:KRT26 | |
| Interaction | KRT5 interactions | 7.67e-09 | 193 | 84 | 10 | int:KRT5 | |
| Interaction | KRT16 interactions | 9.34e-09 | 197 | 84 | 10 | int:KRT16 | |
| Interaction | KRT35 interactions | 2.02e-08 | 111 | 84 | 8 | int:KRT35 | |
| Interaction | KRT32 interactions | 2.72e-08 | 44 | 84 | 6 | int:KRT32 | |
| Interaction | KRT13 interactions | 2.86e-08 | 116 | 84 | 8 | int:KRT13 | |
| Interaction | KRT7 interactions | 4.21e-08 | 80 | 84 | 7 | int:KRT7 | |
| Interaction | KRT15 interactions | 5.57e-08 | 178 | 84 | 9 | int:KRT15 | |
| Interaction | KRT75 interactions | 6.43e-08 | 181 | 84 | 9 | int:KRT75 | |
| Interaction | KIFC3 interactions | 9.59e-08 | 252 | 84 | 10 | int:KIFC3 | |
| Interaction | KRT24 interactions | 9.63e-08 | 54 | 84 | 6 | int:KRT24 | |
| Interaction | KRT33B interactions | 1.20e-07 | 93 | 84 | 7 | int:KRT33B | |
| Interaction | KRT27 interactions | 1.64e-07 | 202 | 84 | 9 | int:KRT27 | |
| Interaction | PRPH interactions | 1.79e-07 | 204 | 84 | 9 | int:PRPH | |
| Interaction | KRT37 interactions | 1.98e-07 | 100 | 84 | 7 | int:KRT37 | |
| Interaction | KRT38 interactions | 6.01e-07 | 172 | 84 | 8 | int:KRT38 | |
| Interaction | DCTN1 interactions | KRT2 KRT3 KRT5 KRT6A KRT6B KRT8 KRT76 KRT6C NDC80 RAB3GAP2 RICTOR EIF2A | 1.00e-06 | 497 | 84 | 12 | int:DCTN1 |
| Interaction | KRT17 interactions | 1.05e-06 | 252 | 84 | 9 | int:KRT17 | |
| Interaction | KRT10 interactions | 1.13e-06 | 187 | 84 | 8 | int:KRT10 | |
| Interaction | KRT18 interactions | KRT2 KRT3 KRT5 KRT6A KRT6B KRT8 KRT76 KRT6C CCNB3 DNAJC3 GFRA1 | 1.31e-06 | 419 | 84 | 11 | int:KRT18 |
| Interaction | KRT19 interactions | 2.66e-06 | 282 | 84 | 9 | int:KRT19 | |
| Interaction | UBASH3B interactions | 4.17e-06 | 157 | 84 | 7 | int:UBASH3B | |
| Interaction | KRT39 interactions | 4.68e-06 | 59 | 84 | 5 | int:KRT39 | |
| Interaction | KRT6C interactions | 1.63e-05 | 76 | 84 | 5 | int:KRT6C | |
| Interaction | KRT6B interactions | 1.88e-05 | 132 | 84 | 6 | int:KRT6B | |
| Interaction | SHC1 interactions | 1.98e-05 | 362 | 84 | 9 | int:SHC1 | |
| Interaction | IQCB1 interactions | 2.35e-05 | 370 | 84 | 9 | int:IQCB1 | |
| Interaction | INPPL1 interactions | 3.13e-05 | 214 | 84 | 7 | int:INPPL1 | |
| Interaction | KRT3 interactions | 3.33e-05 | 88 | 84 | 5 | int:KRT3 | |
| Interaction | KRT77 interactions | 5.06e-05 | 96 | 84 | 5 | int:KRT77 | |
| Interaction | EFNA1 interactions | 7.09e-05 | 103 | 84 | 5 | int:EFNA1 | |
| Interaction | ZUP1 interactions | 8.85e-05 | 174 | 84 | 6 | int:ZUP1 | |
| Interaction | EFNA3 interactions | 8.88e-05 | 108 | 84 | 5 | int:EFNA3 | |
| Interaction | KRT79 interactions | 1.07e-04 | 59 | 84 | 4 | int:KRT79 | |
| Interaction | VIM interactions | KRT2 KRT3 KRT5 KRT6A KRT6B KRT8 KRT76 KRT6C SPTAN1 RICTOR ZNF217 NEB | 1.21e-04 | 804 | 84 | 12 | int:VIM |
| Interaction | KRT73 interactions | 1.47e-04 | 64 | 84 | 4 | int:KRT73 | |
| Interaction | YWHAH interactions | TRAPPC11 KRT8 STOX2 IARS2 PDE3B KIF26B CLMN PPFIBP1 SPTAN1 RAB3GAP2 SYNE2 RICTOR PFKFB3 NSMCE2 | 1.73e-04 | 1102 | 84 | 14 | int:YWHAH |
| Interaction | RGPD2 interactions | 1.90e-04 | 27 | 84 | 3 | int:RGPD2 | |
| Interaction | INSIG1 interactions | 1.90e-04 | 127 | 84 | 5 | int:INSIG1 | |
| Interaction | FGD5 interactions | 2.28e-04 | 207 | 84 | 6 | int:FGD5 | |
| Interaction | NUP43 interactions | DCAF1 PHF2 RANBP1 RAB3GAP2 SYNE2 RICTOR MPHOSPH10 EIF2A ZMYM4 TOP2B | 2.68e-04 | 625 | 84 | 10 | int:NUP43 |
| Interaction | CBL interactions | 2.96e-04 | 516 | 84 | 9 | int:CBL | |
| Interaction | NDC80 interactions | 3.26e-04 | 312 | 84 | 7 | int:NDC80 | |
| Interaction | MEIKIN interactions | 3.56e-04 | 7 | 84 | 2 | int:MEIKIN | |
| Interaction | TRIM54 interactions | 3.87e-04 | 321 | 84 | 7 | int:TRIM54 | |
| Interaction | CEP350 interactions | 3.99e-04 | 149 | 84 | 5 | int:CEP350 | |
| Interaction | KRT76 interactions | 4.20e-04 | 84 | 84 | 4 | int:KRT76 | |
| Interaction | AP2M1 interactions | 4.26e-04 | 430 | 84 | 8 | int:AP2M1 | |
| Interaction | ASB12 interactions | 4.52e-04 | 36 | 84 | 3 | int:ASB12 | |
| Interaction | KRT40 interactions | 4.53e-04 | 434 | 84 | 8 | int:KRT40 | |
| Interaction | KRT74 interactions | 4.90e-04 | 37 | 84 | 3 | int:KRT74 | |
| Interaction | LATS1 interactions | 4.96e-04 | 440 | 84 | 8 | int:LATS1 | |
| Interaction | KRT31 interactions | 6.00e-04 | 453 | 84 | 8 | int:KRT31 | |
| Interaction | YWHAG interactions | TRAPPC11 KRT8 STOX2 IARS2 PDE3B KIF26B CLMN PPFIBP1 SPTAN1 SYNE2 RICTOR PRKCQ PFKFB3 CNTLN | 6.10e-04 | 1248 | 84 | 14 | int:YWHAG |
| Interaction | MPHOSPH9 interactions | 6.70e-04 | 95 | 84 | 4 | int:MPHOSPH9 | |
| Cytoband | 12q13.13 | 4.23e-11 | 67 | 84 | 7 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.15e-06 | 423 | 84 | 8 | chr12q13 | |
| Cytoband | Xp11 | 1.47e-04 | 10 | 84 | 2 | Xp11 | |
| Cytoband | 4q35.1 | 2.00e-03 | 36 | 84 | 2 | 4q35.1 | |
| GeneFamily | Keratins, type II | 1.91e-14 | 27 | 60 | 8 | 609 | |
| GeneFamily | RAB like GTPases | 1.08e-04 | 5 | 60 | 2 | 394 | |
| Coexpression | GU_PDEF_TARGETS_DN | 1.81e-07 | 40 | 84 | 5 | M10480 | |
| Coexpression | DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS | 2.48e-06 | 67 | 84 | 5 | M40299 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 8.87e-06 | 13 | 84 | 3 | MM743 | |
| Coexpression | DCA_UP.V1_DN | 2.94e-05 | 185 | 84 | 6 | M2760 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN | 3.94e-05 | 195 | 84 | 6 | M10007 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | DCAF1 MMRN1 IARS2 PDE3B HEG1 NDC80 ARHGAP26 SYNE2 ZNF770 CDYL DEPDC1 PRKCQ GREB1 MPHOSPH10 CNTLN PCGF3 TOP2B | 6.70e-06 | 1252 | 84 | 17 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_500 | 1.45e-05 | 78 | 84 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | DCAF1 TRAPPC11 STOX2 IARS2 PDE3B HEG1 NEXMIF SYNE2 SNX31 GRIK2 DEPDC1 GREB1 MPHOSPH10 CNTLN PCGF3 ZNF804A DEUP1 | 3.24e-05 | 1414 | 84 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | DCAF1 TRAPPC11 STOX2 IARS2 PDE3B HEG1 NEXMIF SYNE2 DEPDC1 GREB1 MPHOSPH10 CNTLN PCGF3 DEUP1 | 6.61e-05 | 1060 | 84 | 14 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | EB cord blood_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 8.27e-05 | 181 | 84 | 6 | PCBC_ratio_EB cord blood_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#4 | 8.79e-05 | 59 | 84 | 4 | Arv_EB-LF_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.15e-04 | 120 | 84 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | PHF2 RANBP1 STOX2 PDE3B RABL2A KIF26B SYNE2 GRIK2 MPHOSPH10 CNTLN TOP2B DEUP1 LRRC17 | 1.22e-04 | 983 | 84 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 1.50e-04 | 388 | 84 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 5.30e-08 | 181 | 84 | 7 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.93e-08 | 192 | 84 | 7 | 8ad6678df89175c5a4a835c8566f1552df3c996e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.93e-08 | 192 | 84 | 7 | 2f5378ea0b2fb2f672a36585d375f675983363a1 | |
| ToppCell | distal-1-Epithelial-Proliferating_Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.01e-07 | 199 | 84 | 7 | 93450257180d918c310bca7b5defc74390c48091 | |
| ToppCell | distal-Epithelial-Proliferating_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.05e-07 | 200 | 84 | 7 | 25cc494ef831511840d8c02ec1bd086635cc7edd | |
| ToppCell | distal-Epithelial-Proliferating_Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.05e-07 | 200 | 84 | 7 | cc31e8c28d01e6757c5dd7f485db6acf7409a47e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.13e-07 | 165 | 84 | 6 | b1bbf5acdfc52bd8c7c7eb356d73b812eb6b908c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.13e-07 | 165 | 84 | 6 | 28f8297ec7b781149cc7ac2f5e441771083b8ee3 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.22e-06 | 181 | 84 | 6 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|World / Lineage and Cell class | 1.88e-06 | 195 | 84 | 6 | 69723b06c2a5c2aaf4d10874b11bca7f06822bdc | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.94e-06 | 196 | 84 | 6 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.00e-06 | 197 | 84 | 6 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.00e-06 | 197 | 84 | 6 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 198 | 84 | 6 | de5987588b9fa9ee8c595ba06d7d844ead0e3c74 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.06e-06 | 198 | 84 | 6 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-06 | 199 | 84 | 6 | a4ebb0598e9a0c9f6e39a0db6d0623654c2a7d88 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-05 | 160 | 84 | 5 | 18ae6822915d16699beb9047baeef9b006901a35 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-05 | 160 | 84 | 5 | 830f17bad94de05612fe6d53d39e42a4b3f3e2f3 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.57e-05 | 166 | 84 | 5 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 169 | 84 | 5 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-05 | 169 | 84 | 5 | f086b50791e1c93e253eb5e8d6c4bf617b1416c3 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.81e-05 | 171 | 84 | 5 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-05 | 171 | 84 | 5 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-05 | 172 | 84 | 5 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-05 | 172 | 84 | 5 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-05 | 172 | 84 | 5 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.97e-05 | 174 | 84 | 5 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.97e-05 | 174 | 84 | 5 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-SMG_basal_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.97e-05 | 174 | 84 | 5 | aceca0a22bb1e380835e792681cfc9b752fb5496 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 176 | 84 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.14e-05 | 177 | 84 | 5 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.26e-05 | 179 | 84 | 5 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.26e-05 | 179 | 84 | 5 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 180 | 84 | 5 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 180 | 84 | 5 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.57e-05 | 184 | 84 | 5 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-05 | 184 | 84 | 5 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.57e-05 | 184 | 84 | 5 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-05 | 185 | 84 | 5 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 2.85e-05 | 188 | 84 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|Lymphoid / Disease state, Lineage and Cell class | 2.85e-05 | 188 | 84 | 5 | 15057036b46c9df621ec4955aa94ca3036245d45 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 188 | 84 | 5 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-05 | 188 | 84 | 5 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.85e-05 | 188 | 84 | 5 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-05 | 189 | 84 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 3.00e-05 | 190 | 84 | 5 | 10bece40d980d37a01dae8ce887655bf9f93040c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.00e-05 | 190 | 84 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.00e-05 | 190 | 84 | 5 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.00e-05 | 190 | 84 | 5 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.00e-05 | 190 | 84 | 5 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 191 | 84 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.08e-05 | 191 | 84 | 5 | 0f9443da0f73d07456142fae08b2dc92a5b7b592 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.08e-05 | 191 | 84 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.08e-05 | 191 | 84 | 5 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.08e-05 | 191 | 84 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 192 | 84 | 5 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 192 | 84 | 5 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 192 | 84 | 5 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 192 | 84 | 5 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 192 | 84 | 5 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.16e-05 | 192 | 84 | 5 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 193 | 84 | 5 | 735a72fac16397edde95e8eefa6f83caeb5ee5df | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-basal_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.23e-05 | 193 | 84 | 5 | 83d2dd823808a2b5ca1a6889eefb541ec042b24c | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 3.23e-05 | 193 | 84 | 5 | 3c8a022dbd4f8d25b14fd137ce64c2713a7dbe41 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.23e-05 | 193 | 84 | 5 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.23e-05 | 193 | 84 | 5 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 193 | 84 | 5 | ff901d2f3d7a511639c1e3b76058896c0d8a8602 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-05 | 194 | 84 | 5 | 35b30bc954750e939f81a9a7498b8bc2ce69a299 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.40e-05 | 195 | 84 | 5 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.40e-05 | 195 | 84 | 5 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 196 | 84 | 5 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 196 | 84 | 5 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 197 | 84 | 5 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 197 | 84 | 5 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 197 | 84 | 5 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | 3'-Broncho-tracheal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 197 | 84 | 5 | 5d33f8a6940431093e927b186fb9b630a89d8ec1 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-05 | 197 | 84 | 5 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.57e-05 | 197 | 84 | 5 | 9ee927d005eb17843e2516c8006eb192c6ad2af8 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.65e-05 | 198 | 84 | 5 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.65e-05 | 198 | 84 | 5 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | cycling_basal_cell|World / shred by cell class for bronchial biopsy | 3.65e-05 | 198 | 84 | 5 | d5306121a75c5eb37d62c353799a98e6ba5ab63f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.65e-05 | 198 | 84 | 5 | 3371276410dba693c238b383d990b89371b14d8d | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 3.65e-05 | 198 | 84 | 5 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 3.65e-05 | 198 | 84 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 3.65e-05 | 198 | 84 | 5 | 86a4c8e859ce11a95875f8844963baeb1ba898ec | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.65e-05 | 198 | 84 | 5 | 96236fa22545f6f4ff3aa8dc002963db8a3468ce | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-05 | 198 | 84 | 5 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-05 | 198 | 84 | 5 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.65e-05 | 198 | 84 | 5 | 9e0fdd63069d17430cdc25bf4ffc762afd5e1728 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.65e-05 | 198 | 84 | 5 | 7eb521af938c2609a85d27e2aa7d4317ad6e1e44 | |
| ToppCell | proximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.74e-05 | 199 | 84 | 5 | 521ff4ae3437c8ba477a0a42b9da195af976c3ff | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.74e-05 | 199 | 84 | 5 | 8be7cb9d8b4f9707efb69c681c40e683fcd810e5 | |
| ToppCell | proximal-Epithelial-Proliferating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.74e-05 | 199 | 84 | 5 | e8549b2c4152cb23548351d9cee27c3805892cd8 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 199 | 84 | 5 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | proximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.74e-05 | 199 | 84 | 5 | 2263bb73d9c5693b44d91d2548305efc1b6e4079 | |
| ToppCell | Severe-Lymphoid|Severe / Condition, Lineage, Cell class and cell subclass | 3.74e-05 | 199 | 84 | 5 | 928e346b0f31d991ebab12fefb4eb9f4249e601d | |
| ToppCell | Severe-Lymphoid-T|Severe / Condition, Lineage, Cell class and cell subclass | 3.74e-05 | 199 | 84 | 5 | ad2be3739721b7bfc2bd50eafd01d4325b01016e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 199 | 84 | 5 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-05 | 199 | 84 | 5 | 89d7622c4ae146900d963ac68c6bf011e8674665 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.83e-05 | 200 | 84 | 5 | c7668e26c6b8cfa6d174b0634e43c230425faba9 | |
| Computational | Genes in the cancer module 68. | 2.12e-07 | 26 | 57 | 5 | MODULE_68 | |
| Computational | Keratin. | 2.12e-07 | 26 | 57 | 5 | MODULE_298 | |
| Computational | Intermediate filaments and MT. | 2.83e-05 | 68 | 57 | 5 | MODULE_438 | |
| Drug | teleocidin B | 2.88e-11 | 123 | 84 | 10 | CID000072425 | |
| Drug | homocysteine thiolactone | 1.34e-09 | 131 | 84 | 9 | CID000107712 | |
| Drug | AC1L9MJT | 2.31e-09 | 192 | 84 | 10 | CID000448959 | |
| Drug | al-Badry | 1.02e-08 | 165 | 84 | 9 | CID000004545 | |
| Drug | sulfur mustard | 2.75e-08 | 130 | 84 | 8 | CID000010461 | |
| Drug | dithranol | 5.07e-07 | 18 | 84 | 4 | CID000002202 | |
| Drug | plakin | 5.89e-07 | 82 | 84 | 6 | CID000018752 | |
| Drug | SC-791 | 9.61e-07 | 6 | 84 | 3 | CID010291510 | |
| Drug | Velcade (bortezomib | 1.19e-06 | 374 | 84 | 10 | CID000093860 | |
| Drug | cignolin | 2.00e-06 | 56 | 84 | 5 | CID000010187 | |
| Drug | 4,4'-thiodiphenol | 5.73e-06 | 32 | 84 | 4 | CID000017570 | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 7.88e-06 | 195 | 84 | 7 | 5299_UP | |
| Drug | 4-hydroxytestosterone | 1.04e-05 | 78 | 84 | 5 | CID000160615 | |
| Drug | CP-115,953 | 1.35e-05 | 2 | 84 | 2 | CID000119367 | |
| Drug | adenosine 3',5'-cyclic phosphate | IFNG KRT2 KRT3 KRT5 KRT6A KRT6B KRT8 PDE3B KRT76 KRT6C PRKCQ CLIC6 PFKFB3 | 2.66e-05 | 907 | 84 | 13 | CID000000274 |
| Drug | clobestasol propionate | 3.17e-05 | 17 | 84 | 3 | CID000002791 | |
| Drug | mant-GTP | 3.49e-05 | 50 | 84 | 4 | CID000128647 | |
| Drug | Olux | 5.28e-05 | 20 | 84 | 3 | CID000032797 | |
| Drug | N1-acetylspermidine | 5.28e-05 | 20 | 84 | 3 | CID000000496 | |
| Drug | DIMIT | 5.47e-05 | 56 | 84 | 4 | CID000006624 | |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 6250_UP | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; PC3; HT_HG-U133A | 9.02e-05 | 197 | 84 | 6 | 4226_UP | |
| Drug | MK-6 | 9.27e-05 | 24 | 84 | 3 | CID005283547 | |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; PC3; HT_HG-U133A | 9.28e-05 | 198 | 84 | 6 | 4654_DN | |
| Drug | 1-2q | 9.71e-05 | 289 | 84 | 7 | CID000011820 | |
| Drug | Bhg-(2-1)fuc | 1.05e-04 | 25 | 84 | 3 | CID005287784 | |
| Disease | Malignant neoplasm of breast | IFNG CNNM4 KRT5 RANBP1 KRT8 KRT76 PPP1R12B SPTAN1 TRPC4 SYNE2 GRIK2 DTX3L NSMCE2 | 7.95e-06 | 1074 | 82 | 13 | C0006142 |
| Disease | sphingomyelin measurement | 1.27e-05 | 278 | 82 | 7 | EFO_0010118 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 4.56e-05 | 4 | 82 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 4.56e-05 | 4 | 82 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia congenita syndrome | 4.56e-05 | 4 | 82 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 4.56e-05 | 4 | 82 | 2 | C1721007 | |
| Disease | Pachyonychia Congenita | 7.59e-05 | 5 | 82 | 2 | C0265334 | |
| Disease | cutaneous squamous cell carcinoma | 1.06e-04 | 33 | 82 | 3 | EFO_1001927 | |
| Disease | response to radiation, Abnormality of the urinary system | 3.38e-04 | 10 | 82 | 2 | GO_0009314, HP_0000079 | |
| Disease | squamous cell carcinoma | 8.72e-04 | 67 | 82 | 3 | EFO_0000707 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 1.03e-03 | 71 | 82 | 3 | EFO_0004735, EFO_0007965 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NAFLRKEFSDLEKKF | 201 | Q9NXG0 | |
| LKAQFSKLTNNFEKL | 96 | Q05D60 | |
| KFSAFIKNTKKDANE | 576 | Q96NY7 | |
| LKAASKLKNDNTEAF | 211 | Q13217 | |
| NFKEDSLVKESLAFK | 356 | Q8WWL7 | |
| RFLNAENAQKFKTKF | 141 | P43487 | |
| KKFIAKKLNLSSFNE | 186 | Q3KNV8 | |
| QIKTLNNKFASFIDK | 186 | Q01546 | |
| EKEQIKTLNNKFASF | 91 | P05787 | |
| DDINVTQKSFNFAKK | 136 | Q9UBK7 | |
| DDINVTQKSFNFAKK | 136 | Q9UNT1 | |
| LFDSKGKNAFFKDLT | 1181 | Q9H2M9 | |
| ENFRKAKQKLGFSSS | 276 | Q9Y4B6 | |
| QIKTLNNKFASFIDK | 166 | P48668 | |
| LAEFKKTNQFFAIKA | 396 | Q04759 | |
| KLDTEAQTKFKAFLQ | 741 | Q4ZG55 | |
| QIKTLNNKFASFIDK | 166 | P02538 | |
| AFSNFGNLRKKKQED | 906 | Q86W92 | |
| ALSDLEENDFKKLKF | 16 | Q86W26 | |
| SKKDSFSNLELKFCF | 521 | Q86W26 | |
| EKFKDKDFALDVSAN | 586 | Q16832 | |
| LSKCRNDFKFQLKDT | 596 | Q13201 | |
| FSKFKKLKSLDLQQN | 101 | Q8N6Y2 | |
| FFARAAQKLNLSSKK | 386 | Q2KJY2 | |
| QIKTLNNKFASFIDK | 181 | P35908 | |
| QIKTLNNKFASFIDK | 201 | P12035 | |
| QIKTLNNKFASFIDK | 171 | P13647 | |
| KVAFNAFKNKILSDI | 476 | P98073 | |
| KKINKNDFASLSDLK | 156 | Q99645 | |
| QIKTLNNKFASFIDK | 166 | P04259 | |
| SLKKFLDTAFNLQAF | 991 | Q9ULD0 | |
| KKHFDFLAEFNAKAN | 896 | Q13370 | |
| KKFASALSKFVEEQN | 276 | Q16875 | |
| KKFLALQSKNSDADF | 106 | Q96MF7 | |
| NIENFSKDKDSIFKL | 126 | Q5TB30 | |
| KDKALKSSQAFFSKL | 636 | O00566 | |
| KSSQAFFSKLQDQVK | 641 | O00566 | |
| NKNDISKLIFKSGDF | 1276 | Q9ULI3 | |
| KLYANLDLDFAKAKQ | 586 | Q6R327 | |
| DFCRDSNVSLKFNKK | 391 | Q92794 | |
| DLPSDKAKFENFNKA | 286 | O94856 | |
| KAKFENFNKALRITN | 291 | O94856 | |
| NLKQFSSKDDFKLAV | 851 | Q2UY09 | |
| SKNSQLFAASQKFRK | 161 | Q9Y232 | |
| EKANKLAVIKFSDSN | 3096 | Q8TD57 | |
| SLADSKQANKFKQEL | 311 | Q8TDB6 | |
| LKFLNFFKDNTCLKN | 326 | P56159 | |
| FNARKLDDKDFFSKS | 161 | Q96A23 | |
| EFKLQKLKRSQNSAF | 331 | Q86UW7 | |
| NFKDARDAEQLSKNK | 16 | Q9NRW4 | |
| NVKFFNSNKKKRDDF | 101 | P01579 | |
| AALANKSFFKADKVT | 211 | Q9BY44 | |
| QKINLYDSFEASKKA | 81 | Q13002 | |
| AYLDKEFSKAQKALS | 46 | Q4V328 | |
| FDKSAFDIALEKNNA | 136 | Q8TAK5 | |
| KDNKFSFSFSNKKLL | 631 | O75151 | |
| SKCQLSEKFFKAASN | 411 | Q02880 | |
| KSAASALKFDKDLAN | 451 | Q4G0N8 | |
| IIKKLNENKTFDDSF | 3101 | Q8WXH0 | |
| ADSFKKIFDEAKTAQ | 1446 | P0DJD1 | |
| KSGALKQSSDFSQFK | 351 | Q5QGS0 | |
| KAKDLPTFKDNDFLN | 231 | P78356 | |
| AKRKFADSLNEFKFQ | 56 | Q9UNA1 | |
| SFAKAAIEKQKSAFI | 186 | Q9NSE4 | |
| KLEAFQKEDSQTKFL | 246 | Q8N9S9 | |
| AKAKALFNTLKEQAS | 106 | Q9P291 | |
| LKASKFNSDLIDFAS | 561 | Q96JQ2 | |
| EKNKRDFSAFKDADN | 526 | Q6P4Q7 | |
| DFSAFKDADNELKVK | 531 | Q6P4Q7 | |
| AFFSELKQDTQNALK | 231 | Q7Z392 | |
| KKDKTKQLANFSAQF | 276 | Q9P2F5 | |
| DLFLTFAKKASAFNS | 2091 | Q13813 | |
| AAINFALEQLFKKSK | 576 | Q6UXI7 | |
| KRNAAEKFLAKFSNI | 181 | O75569 | |
| LDNFQSEKKVFKKSF | 351 | Q6IQ21 | |
| KECDKAFKQFSLLSQ | 426 | Q15928 | |
| KDFNIKLSDFSFSKR | 146 | Q9BXA7 | |
| SAQTKNLKRFFDGAK | 551 | O75362 | |
| KNKTLSEDDFRKFFQ | 1506 | Q01118 | |
| FDLAKAQENSNSVKK | 131 | Q15650 | |
| KKFAADFAAEAASKT | 186 | Q8TF42 | |
| SKKLAESAQGKNIFF | 16 | P48595 | |
| DSRLKSSFFDKAANQ | 191 | Q5VZL5 | |
| NSKDKKKNFSLFDLT | 786 | Q9UBN4 | |
| CFDFKSTKVNNNLDK | 461 | Q7Z570 | |
| SDLNSKIQSGFFKNK | 321 | O60237 | |
| QSKLKDLFNVDAFKL | 251 | O14777 | |
| KFKLDTVLQNFSSDK | 406 | P20929 |